Artemis Medicare Services Limited (ARTEMISMED.NS)
INR 281.85
(0.25%)
INR 281.85
(0.25%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.08 Billion | 1.12 Billion | 515.8 Million | 182.38 Million | 460.47 Million | 328.75 Million |
| Net Income | 491.4 Million | 385.97 Million | 318.14 Million | 64.85 Million | 197.92 Million | 204.92 Million |
| Depreciation & Amortization | 403.16 Million | 310.04 Million | 221.92 Million | 215.13 Million | 226.3 Million | 200.74 Million |
| Deferred income taxes | - | 193.91 Million | 145.41 Million | - | - | - |
| Stock-based compensation | 21.75 Million | 40.3 Million | 77.52 Million | - | - | - |
| Change in working capital | -214.54 Million | 301.76 Million | 219 Thousand | -124.29 Million | -42.15 Million | -126.54 Million |
| Other non-cash items | 386.76 Million | 692.63 Million | 607 Million | 419.41 Million | 546.15 Million | 609.63 Million |
| Investing Cash Flow | -869.9 Million | -1.57 Billion | -1.07 Billion | -378.46 Million | -259.17 Million | -508.42 Million |
| Investments in PPE | -725.53 Million | -1.46 Billion | -1.08 Billion | -345.01 Million | -260.03 Million | -572.66 Million |
| Acquisitions | 21.09 Million | 48.3 Million | 10.6 Million | 45.67 Million | 9.86 Million | 862 Thousand |
| Investment purchases | -186.6 Million | -160.74 Million | -413 Thousand | -79.13 Million | -9 Million | - |
| Sales/Maturities of investments | - | 117.4 Million | -16.77 Million | 29.22 Million | 2.88 Million | 63.37 Million |
| Other Investing Activities | -144.37 Million | -117.4 Million | 16.77 Million | -29.22 Million | -2.88 Million | -1000.00 |
| Financing Cash Flow | -301.24 Million | 521.81 Million | 528.37 Million | 271.61 Million | -177.61 Million | 232.66 Million |
| Debt repayment | -81.44 Million | -579.72 Million | -561.83 Million | -295.87 Million | -163.91 Million | -232.66 Million |
| Dividends payments | -61.13 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.74 Million | 1.74 Million | - | - | - | - |
| Other Financing Activities | -321.55 Million | -3.88 Million | -103.16 Million | -220.11 Million | -366.49 Million | 290.11 Million |
| Accounts receivables | -37.1 Million | -218.27 Million | -195.21 Million | 191.13 Million | 7.72 Million | -246.34 Million |
| Accounts payables | 74.9 Million | 290.92 Million | 35.3 Million | -164.88 Million | 15.3 Million | 92.71 Million |
| Inventory | 39.08 Million | -15.94 Million | -27.72 Million | 11.29 Million | -38.16 Million | -4.89 Million |
| Other working capital | -216.53 Million | 245.05 Million | 187.85 Million | -161.84 Million | -27.02 Million | 31.97 Million |
| Cash at beginning of period | 228.68 Million | 156.98 Million | 191.62 Million | 116.08 Million | 92.38 Million | 44.62 Million |
| Cash at end of period | 146.08 Million | 228.68 Million | 156.98 Million | 191.62 Million | 116.08 Million | 92.38 Million |
| Capital Expenditure | -725.53 Million | -1.46 Billion | -1.08 Billion | -345.01 Million | -260.03 Million | -572.66 Million |
| Effect of forex changes on cash | - | - | - | - | -1.00 | 12.42 Million |
| Net cash flow / Change in cash | -82.59 Million | 71.69 Million | -34.63 Million | 75.53 Million | 23.69 Million | 47.76 Million |
| Free Cash Flow | 363.01 Million | -337.67 Million | -573.2 Million | -162.62 Million | 200.44 Million | -243.91 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 166.66 Million | 491.4 Million | 141.79 Million | 115.49 Million | 135.93 Million | 98.18 Million |
| Depreciation & Amortization | - | 403.16 Million | - | 101.57 Million | 99.53 Million | 91.67 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 21.75 Million | 21.75 Million | - | - | - |
| Change in working capital | - | -139.64 Million | - | - | - | - |
| Other non-cash items | -166.66 Million | 824.44 Million | -163.54 Million | -115.49 Million | -135.93 Million | -98.18 Million |
| Investing Cash Flow | - | -891.04 Million | - | - | - | - |
| Investments in PPE | - | -725.53 Million | - | - | - | - |
| Acquisitions | - | 21.09 Million | - | - | - | - |
| Investment purchases | - | -186.6 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -144.37 Million | - | - | - | - |
| Financing Cash Flow | - | -41.48 Million | - | - | - | - |
| Debt repayment | - | -120.27 Million | - | - | - | - |
| Dividends payments | - | -61.13 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1.74 Million | - | - | - | - |
| Other Financing Activities | - | -11.44 Million | - | - | - | - |
| Accounts receivables | - | -37.1 Million | - | - | - | - |
| Accounts payables | - | 74.9 Million | - | - | - | - |
| Inventory | - | 39.08 Million | - | - | - | - |
| Other working capital | - | -216.53 Million | - | - | - | - |
| Cash at beginning of period | - | 228.68 Million | - | 206.35 Million | 7.29 Million | 228.68 Million |
| Cash at end of period | - | 147.46 Million | - | 409.5 Million | 206.35 Million | 412.03 Million |
| Capital Expenditure | - | -725.53 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -81.22 Million | - | 203.15 Million | 199.06 Million | 183.34 Million |
| Free Cash Flow | - | 124.39 Million | - | 203.15 Million | 199.06 Million | 183.34 Million |
AUMC
PEB-PG
ABLV
MASN
7TEC
BVNNF